Maz Ganat, MD

Urologic Oncology, Urology

 I am dedicated to providing you the best care possible and helping you choose the best treatment that is right for you. I look forward to meeting you and thank you for choosing me as your doctor.  

Locations & Appointments
Show Menu

Primary Areas of Practice

  • Urologic Oncology
  • Urology

Other Areas of Practice

  • Bloodless Medicine


  • Adrenalectomy
  • Bloodless Medicine & Surgery
  • Cystectomy
  • Cystoscopy
  • Endoscopic Surgery
  • Kidney-Sparing Surgery
  • Laparoscopic Nephrectomy
  • Lithotripsy
  • Minimally Invasive Surgery
  • MRI/Ultrasound Fusion Prostate Biopsy
  • Nephrectomy
  • Nephrolithotomy
  • Orchiectomy
  • Partial Cystectomy
  • Partial Nephrectomy
  • Percutaneous Transurethral Resection
  • Pyeloplasty
  • Robotic Nephrectomy
  • Robotic Prostatectomy
  • Robotic Surgery
  • Ureteroscopy (With or Without Biopsy)

Conditions Treated

  • Adrenal Cancer
  • Benign Prostatic Hyperplasia (BPH)
  • Bladder Cancer
  • Enlarged Prostate
  • Hematuria
  • Kidney Cancer
  • Kidney Stones
  • Prostate Cancer
  • Prostate Disorders
  • Renal Cancer
  • Testicular Cancer
  • Urologic Cancer
  • Urologic Disorders


Urology at Englewood


350 Engle Street Suite 6530 Englewood, NJ 07631 Directions 

Phone: 201-608-2849
Fax: 201-608-2772
Monday: 8:00 AM – 5:00 PM

Urology at Fair Lawn


22-18 Broadway Suite 301 Fair Lawn, NJ 07410 Directions 

Phone: 973-321-2755
Fax: 973-321-2750
Tuesday: 9:00 AM – 12:00 PM
Dr. Ganat sees patients in Fair Lawn on the first Tuesday of each month.

Englewood Health ZT Systems Outpatient Center at Jersey City


2 Journal Square Plaza 2nd Floor, Medical Suites Jersey City, NJ 07306 Directions 

Phone: 201-963-7000
Fax: 201-963-8334


Book Online

Insurances Accepted

Please contact your insurance company directly prior to receiving services or care to confirm your coverage. Although we have made every effort to ensure this list is accurate, only your health insurance plan can provide complete information regarding your coverage and potential out-of-pocket costs.

1199 (SEIU)

  • 1199 (SEIU)


  • Aetna Assure Premier Plus
  • Aetna Better Health of New Jersey
  • Aetna CCN
  • Aetna CoreSource
  • Aetna Coventry
  • Aetna FIDE-SNP
  • Aetna HMO
  • Aetna Medicare Managed Care
  • Aetna POS
  • Aetna PPO
  • Aetna Whole Health HMO
  • Aetna Whole Health PPO
  • Medsolutions
  • Meritan Health


  • AmeriHealth Administrator
  • AmeriHealth HMO
  • AmeriHealth PPO
  • Value Network (Exchange Plan)


  • APWU Health Plan


  • Cigna HMO
  • Cigna Medicare Advantage
  • Cigna Open Access Plus
  • Cigna PPO
  • Cigna Supplemental
  • Great-West Healthcare (GWH)
  • Health Partners

Clover Health

  • Clover Medicare Advantage


  • EmblemHealth EPO
  • EmblemHealth EPO2
  • EmblemHealth FEHB
  • EmblemHealth FEHBP
  • EmblemHealth GHI CBP
  • EmblemHealth GHI PPO
  • EmblemHealth National
  • EmblemHealth PPO1
  • EmblemHealth PPO2
  • EmblemHealth PPO3
  • EmblemHealth Tri-State
  • Vytra

Empire BCBS

  • Blue Priority
  • Direct HMO
  • Direct PPO
  • Empire BCBS EPO
  • Empire BCBS GEPO
  • Empire BCBS HealthPlus Gatekeeper (prefix VFG)
  • Empire BCBS HealthPlus Gatekeeper (prefix VJD)
  • Empire BCBS HMO
  • Empire BCBS Indemnity
  • Empire BCBS Medicare Advantage
  • Empire BCBS Medicare Advantage Plus
  • Empire BCBS POS
  • Empire BCBS PPO

Empire Plan (NYSHIP)

  • Empire Plan (NYSHIP)

Fidelis Care NJ

  • Fidelis Care NJ Medicaid Managed Care

First Health

  • First Health


  • GEHA Health Plan

Horizon BCBS

  • Federal Employee Program
  • Horizon BCBS Braven Health
  • Horizon BCBS EPO
  • Horizon BCBS HMO
  • Horizon BCBS Medicare Managed Care
  • Horizon BCBS PPO
  • NJ Carpenters Fund
  • OMNIA Tier 1
  • Traditional

Horizon NJ Health

  • Horizon NJ Health Medicaid
  • Horizon NJ TotalCare (D-SNP)


  • Humana ChoiceCare Network PPO
  • Humana ChoiceCare+ Network PPO
  • Humana ChoicePOS
  • Humana Gold Choice Network PFFS
  • Humana Gold Choice Network PFFS 23
  • Humana Gold Plus DE-SNP
  • Humana Gold Plus HMO
  • Humana Medicare (Employer PPO Plus)
  • Humana Medicare PPO
  • Humana Medicare PPO 2023
  • Humana National Medicare HMO
  • Humana National POS - Open Access
  • Humana National POS - Open Access Plus


  • Local 825
  • MagnaCare PPO

Mail Handlers

  • Mail Handlers Benefit Plan (MHBP)


  • Medicaid NJ


  • Medicare NJ


  • Beech Street
  • MultiPlan Humana
  • MultiPlan Worker's Comp
  • PHCS
  • Pomco

MVP Health Care

  • MVP Health Care PPO


  • NALC Health Benefit Plan

Nippon Life Insurance Co of America

  • Nippon Life Benefits


  • Freedom
  • Garden State Network
  • Liberty
  • Metro
  • Oxford Medicare


  • Choice Care
  • Oscar
  • QualCare EPO
  • QualCare FEHB
  • QualCare GHI PPO
  • QualCare HMO
  • QualCare Humana
  • QualCare PPO
  • QualCare Worker's Comp

Railroad Medicare

  • Railroad Medicare NJ

TRICARE North Region

  • DVA


  • UMR

United Healthcare Community and State

  • Dual Complete
  • UnitedHealthcare Community and State Medicaid (NJ FamilyCare)
  • UnitedHealthcare Community and State Medicare


  • AARP
  • Commercial and Marketplace
  • Compass Benefit (Exchange)
  • Medica
  • River Valley
  • UnitedHealthcare EPO
  • UnitedHealthcare HMO
  • UnitedHealthcare POS
  • UnitedHealthcare PPO
  • UnitedHealthcare StudentResources

Wellcare NJ

  • Wellcare NJ Ambetter
  • Wellcare NJ Medicare Managed Care


  • Wellpoint Medicaid
  • Wellpoint Medicare Advantage

About Maz Ganat

Dr. Ganat, Program Director of Urologic Oncology at Englewood Hospital, specializes in cancers of the prostate, bladder, kidney, testes, and penis and performs both open and robotic surgeries. He obtained his MD from SUNY Downstate College of Medicine and did his internship in surgery and residency in urology at SUNY Downstate Medical Center. Following his residency, Dr. Ganat completed a urologic oncology fellowship at Memorial Sloan Kettering Cancer Center. He is a member of the American Urological Association and the Society of Urologic Oncology. Dr. Ganat's research interests are the immunogenomics of urologic malignancies and precision medicine.

Honors & Awards

2020, 2019: Bergen Magazine Top Doctors

Arnold P. Gold Foundation Humanism Award

Professional Memberships

American Urological Association

Society of Urologic Oncology

Committees and Leadership Positions

 Chief, Department of Urology

Education & Degrees

MD: SUNY Downstate College of Medicine


SUNY Downstate Medical Center


Memorial Sloan Kettering Cancer Center: Urologic Oncology

Certifications & Distinctions

  • Urology (American Board of Urology)


Gatto F, Blum KA, Hosseini SS, Ghanaat M, Kashan M, Maccari F, Galeotti F, Hsieh JJ, Volpi N, Hakimi AA, andNielsen J. Plasma glycosaminoglycans as diagnostic and prognostic biomarkers in surgically treated renal cellcarcinoma. Accepted to European Urology Oncology. May 2018

Mendonca S, Sanchez A, Blum K, Ghanaat M, Kashan M, Becerra M, Manley B, Benfante N, Russo P, Coleman J,Crago A, Hakimi AA The Association of Renal Cell Carcinoma with Gastrointestinal Stromal Tumors. The Journal ofSurgical Oncology. Accepted March, 2018 In Press

Kashan M, Ghanaat M, Hötker AM, Duzgol C, Sanchez A, DiNatale RG, Blum KA, Becerra M, Manley BJ, Casuscelli J,Chiok M, Tikoo S, Akin O, Coleman JA, Russo P, Hakimi AA. Cystic renal cell carcinoma: a report on outcomes ofsurgery and active surveillance in patients retrospectively identified on pretreatment imaging. The Journal of Urology. 2018 Feb 26.

Comparison of Postoperative Ileus Rates Using GIA-80 versus GIA-60 Intestinal Stapler Device after RadicalCystectomy. Ghanaat M, Winer AG, Sjoberg DD, Poon BY, Kashan M, Tin AL, Sfakianos JP, Cha EK, Dalbagni G, HerrHW, Bochner BH, Vickers AJ, and Donat SM. Submitted.

Characterizing Recurrent and Lethal Small Renal Masses in Clear Cell Renal Cell Carcinoma Using Recurrent SomaticMutations.Manley BJ, Reznik E, Ghanaat M, Kashan M, Becerra MF, Casuscelli J, Tennenbaum D, Redzematovic A, Carlo MI,Sato Y, Arcila ME, Voss MH, Feldman DR, Motzer RJ, Russo P, Coleman J, Hsieh JJ, Hakimi AA. Urologic Oncology:Seminars and Original Investigations 2017 Nov 11. Elsevier.

Comparative Genomic Profiling of Matched Primary and Metastatic Tumors in Renal Cell Carcinoma. Becerra MF,Reznik E, Redzematovic A, Tennenbaum DM, Ghanaat M, Kashan M, Casuscelli J, Manley BJ, Arcila ME, Carlo MI,Lee CH, Voss MH, Feldman DR, Motzer RJ, Coleman JA, Russo P, Cheng EH, Hakimi AA, and Hsieh JJ. EuropeanUrology Focus. 2017 Oct 20.7. Characterization and impact of TERT promoter region mutations on clinical outcome in renal cell carcinoma.Casuscelli J, Becerra MF, Manley BJ, Zabor EC, Reznik E, Redzematovic D, Arcila ME, Tennenbaum DM, GhanaatM, Kashan M, Stief CG, Carlo MI, Voss MH, Feldman DR, Motzer RJ, Chen Y, Reuter VE, Coleman JA, Russo P, HsiehJJ, Hakimi AA. European Urology Focus. 2017 Sep 23.

Prognostic value of lymph node yield during nephroureterectomy for upper tract urothelial carcinoma. Winer AG,Vertosick EA, Ghanaat M, Corradi RB, Carlsson S, Sjoberg DD, Sankin AI, Sfakianos JP, Cha EK, Dalbagni G, ColemanJA. In Urologic Oncology: Seminars and Original Investigations 2017 Apr 30 (Vol. 35, No. 4, pp. 151-e9). Elsevier.

Secondary pelvic congestion syndrome: description and radiographic diagnosis. Winer AG, Chakiryan NH, MooneyRP, Verges D, Ghanaat M, Allaei A, Robinson L, Zinn H, Lang EK. The Canadian Journal of Urology. 2014Aug;21(4):7365-8.